UY36563A - METHOD FOR IMPROVING GABAB RECEPTOR THERAPY WITH AGONIST - Google Patents

METHOD FOR IMPROVING GABAB RECEPTOR THERAPY WITH AGONIST

Info

Publication number
UY36563A
UY36563A UY0001036563A UY36563A UY36563A UY 36563 A UY36563 A UY 36563A UY 0001036563 A UY0001036563 A UY 0001036563A UY 36563 A UY36563 A UY 36563A UY 36563 A UY36563 A UY 36563A
Authority
UY
Uruguay
Prior art keywords
improving
gabab receptor
agonist
receptor therapy
therapy
Prior art date
Application number
UY0001036563A
Other languages
Spanish (es)
Inventor
Mark A Aikman
Glenn A Meyer
Gustavo A Fischbein
Wright Gene
Original Assignee
Osmotica Pharmaceutical Argentina S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osmotica Pharmaceutical Argentina S A filed Critical Osmotica Pharmaceutical Argentina S A
Publication of UY36563A publication Critical patent/UY36563A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención provee un método para mejorar la terapia de un agonista del receptor GABAB. La invención también provee métodos para la administración de la forma de dosificación y para tratar condiciones que responden terapéuticamente a un agonista del receptor GABAB.The present invention provides a method for improving the therapy of a GABAB receptor agonist. The invention also provides methods for administration of the dosage form and for treating conditions that respond therapeutically to a GABAB receptor agonist.

UY0001036563A 2015-02-20 2016-02-19 METHOD FOR IMPROVING GABAB RECEPTOR THERAPY WITH AGONIST UY36563A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562119017P 2015-02-20 2015-02-20

Publications (1)

Publication Number Publication Date
UY36563A true UY36563A (en) 2016-09-30

Family

ID=57132875

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036563A UY36563A (en) 2015-02-20 2016-02-19 METHOD FOR IMPROVING GABAB RECEPTOR THERAPY WITH AGONIST

Country Status (3)

Country Link
AR (1) AR103731A1 (en)
CL (1) CL2016000383A1 (en)
UY (1) UY36563A (en)

Also Published As

Publication number Publication date
AR103731A1 (en) 2017-05-31
CL2016000383A1 (en) 2016-11-04

Similar Documents

Publication Publication Date Title
CU20160185A7 (en) HETEROARILO COMPOUNDS FOR INHIBITION OF CINASA
BR112018010464A2 (en) topical pharmaceutical formulations to treat related inflammatory conditions
CO2018000809A2 (en) Antibodies for cd40
SV2018005709A (en) 3-AZABICICLO [3.1.0] HEXANOS REPLACED AS INHIBITORS OF CETOHEXOQUINASE
IL251669A0 (en) Treatment of cancer using tlr9 agonist with checkpoint inhibitors
CL2018003123A1 (en) Combination therapy for cancer treatment
CL2016000055A1 (en) Methods to treat or prevent ophthalmic conditions
MX2018016193A (en) Methods of treating ovarian cancer.
BR112018003984A2 (en) antibodies
CO2017005034A2 (en) Recombinant Alkaline Phosphatase Seizure Treatment
BR112017023269A2 (en) methods for cancer treatment
EA201790932A1 (en) DOSAGE AND ADMINISTRATION OF NONFUCULATED ANTI-CD40 ANTIBODIES
CL2017001046A1 (en) Bromodomain Inhibitors
MX2017014191A (en) Methods of treating a neurodegenerative disease.
IL258762B (en) Methods of treating pain using pharmaceutically active acetaminophen dimers linked through phenolic hydroxyl groups
CL2017001960A1 (en) Methods of treating inflammatory diseases
CY1122469T1 (en) SUBLINGUAL PHARMACEUTICAL FORM OF RILOUZOLE
CL2018000597A1 (en) Methods to treat inflammatory diseases
TW201713333A (en) Methods of treating a neurodegenerative disease
CO2017010808A2 (en) Systems and methods for active surveillance of prostate cancer
MX2019003069A (en) Use of pridopidine for treating rett syndrome.
MY195000A (en) Method for the treatment of neurological disease
IL272934A (en) High concentration dosage forms of pridopidine
HUE050024T2 (en) Treatment of autoimmune disorders with cd154 antibodies
BR112017024163A2 (en) bicyclic compounds

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20221104